CLS CLS Special Populations in Lipid Management 2

Question 1

In patients with type 1 diabetes, what lipid abnormality is most commonly seen when diabetes is well-controlled?

Accepted Answer

Near-normal lipid profiles, as insulin facilitates lipid metabolism

Answer

Well-controlled type 1 diabetes is associated with near-normal or even above-normal HDL-C and relatively normal lipid profiles due to adequate insulin levels.

Question 2

A post-menopausal woman is considering hormone replacement therapy (HRT). Which lipid effect distinguishes oral from transdermal estrogen preparations?

Accepted Answer

Oral estrogen increases triglycerides; transdermal estrogen has minimal triglyceride effect

Answer

Oral estrogen undergoes first-pass hepatic metabolism, stimulating VLDL and triglyceride production, whereas transdermal estrogen bypasses the liver and has minimal triglyceride impact.

Question 3

In patients with metabolic syndrome, which lipid triad is characteristically found?

Accepted Answer

Elevated triglycerides, low HDL-C, and increased small dense LDL particles

Answer

Metabolic syndrome classically presents with the atherogenic dyslipidemia triad: hypertriglyceridemia, low HDL-C, and predominance of small dense LDL particles.

Question 4

Which statin dose adjustment is recommended in patients with severe hepatic impairment (Child-Pugh Class C)?

Accepted Answer

Statins are contraindicated in active liver disease and severe hepatic impairment

Answer

Statins are contraindicated in patients with active liver disease or unexplained persistent elevations of hepatic transaminases, including severe hepatic impairment.

Question 5

In patients undergoing solid organ transplantation on cyclosporine, which statin interaction is most clinically significant?

Accepted Answer

Cyclosporine markedly increases statin levels by inhibiting CYP3A4 and OATP1B1, increasing myopathy risk

Answer

Cyclosporine inhibits both CYP3A4 and OATP1B1 transporters, dramatically increasing systemic statin exposure and myopathy/rhabdomyolysis risk.

(CLS) Clinical Lipid Specialist Certification Practice Test

(CLS) Clinical Lipid Specialist Certification Practice Test

CLS CLS Special Populations in Lipid Management 2